Medtronic (MDT) Accounts Payables (2014 - 2026)

Medtronic has disclosed Accounts Payables across 13 years of filings, most recently posting $2.6 billion for Q1 2026.

• Accounts Payables for Q1 2026 came in at $2.6 billion, up 12.38% year-over-year; the trailing twelve-month figure through Jan 2026 was $2.6 billion (up 12.38% YoY), and the FY2025 annual result was $2.4 billion, up 1.62% from the prior year.
• Accounts Payables came in at $2.6 billion for Q1 2026 at Medtronic, roughly flat from $2.6 billion in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $2.7 billion in Q2 2023 to a low of $2.0 billion in Q1 2022.
• The 5-year median for Accounts Payables is $2.3 billion (2025), against an average of $2.3 billion.
• Across the five-year window, Accounts Payables rose 16.96% in 2023 and retreated 9.82% in 2024, its largest moves.
• Medtronic's Accounts Payables stood at $2.2 billion in 2022, then retreated by 1.09% to $2.2 billion in 2023, then grew by 9.29% to $2.4 billion in 2024, then climbed by 8.63% to $2.6 billion in 2025, then retreated by 0.46% to $2.6 billion in 2026.
• The last three Accounts Payables figures came in at $2.6 billion (Q1 2026), $2.6 billion (Q4 2025), and $2.6 billion (Q3 2025), per Business Quant data.